Bifunctional enzyme deficiency is a dubious disease that belongs to the field of genetic metabolism, clinical performance is complex and often involves multi-systematic stress. Early identification and normalisation of clinical trials are essential for improving prognosis. Diagnosis of this disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
Platforms can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of bifunctional enzyme deficiency require individual development, usually including drug therapy, rehabilitation interventions, regular follow-up management, etc. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to disease changes. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of bifunctional enzyme deficiencies. The platform serves China International Medical Service System, a team of nationally and internationally authoritative experts in the field of genetic metabolism who provide the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.